您当前的位置:
首页 >
文章列表页 >
Pharmacoeconomic evaluation of serplulimab combined with chemotherapy regimens for the first-line treatment of extensive-stage small-cell lung cancer
更新时间:2023-06-09
    • Pharmacoeconomic evaluation of serplulimab combined with chemotherapy regimens for the first-line treatment of extensive-stage small-cell lung cancer

    • ZHONGGUO YAOFANG   Vol. 34, Issue 11, Pages: 1368-1373(2023)
    • DOI:10.6039/j.issn.1001-0408.2023.11.16    

      CLC: R956;R979.1
    • Published:15 June 2023

      Received:08 November 2022

      Revised:14 May 2023

    扫 描 看 全 文

  • QI Ran,NIE Xuyang,LIU Xuting,et al.Pharmacoeconomic evaluation of serplulimab combined with chemotherapy regimens for the first-line treatment of extensive-stage small-cell lung cancer[J].ZHONGGUO YAOFANG,2023,34(11):1368-1373. DOI: 10.6039/j.issn.1001-0408.2023.11.16.

  •  
  •  

0

Views

3

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Cost-utility analysis of sintilimab combined with chemotherapy in first-line treatment of advanced, recurrent or metastatic esophageal squamous cell carcinoma
Cost-utility analysis of trastuzumab deruxtecan versus trastuzumab emtansine in the second-line treatment for HER2-positive metastatic breast cancer
Pharmacoeconomics of ivabradine in the treatment of CHF in the context of “Quadruple Therapy”
Study on pharmacoeconomic evaluation of vericiguat in the treatment of heart failure with reduced ejection fraction
Pharmacoeconomic evaluation of sugemalimab consolidation therapy for stage Ⅲ non-small cell lung cancer

Related Author

CHEN Qiuping
SHAO Mingyi
ZHANG Rongrong
CHEN Xiaoqi
WU Yanan
WU Fang
HOU Yanhong
CHEN Congling

Related Institution

First College of Clinical Medicine, Henan University of Chinese Medicine
Dept. of Gastroenterology, the First Affiliated Hospital of Henan University of Chinese Medicine
School of International Pharmaceutical Business, China Pharmaceutical University
Dept. of Pharmacy, Nanjing Drum Tower Hospital
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
0